FARZANEH MOUSAVI: Open Payments
NPI 1922572486 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 6 payments from 6 companies in 2025. Trend: 2023 $249 · 2024 $84 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 1 | $122 |
| ABBVIE INC. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: CREXONT, QULIPTA, WAINUA, UPLIZNA, FIRDAPSE, INGREZZA.
Industry payments across CA — which companies pay providers there.
